Perfil
Nicolas Serandour is Director at Advanced Oncotherapy Plc since 2024, Chief Operating & Financial Officer at Totally Listed Ltd., and President at Neurinnov SAS since 2024.
Formerly, Mr. Serandour was Head-Healthcare Europe at Lazard & Co. Ltd. from 2008 to 2014.
Education includes a graduate degree from Université Paris Dauphine-PSL.
Cargos activos de Nicolas Serandour
| Empresas | Cargo | Inicio |
|---|---|---|
| ADVANCED ONCOTHERAPY PLC | Director/Miembro de la Junta | 27/08/2014 |
Totally Listed Ltd.
Totally Listed Ltd. Financial ConglomeratesFinance Provides investment services | Director Financiero/CFO | - |
Neurinnov SAS
Neurinnov SAS Medical SpecialtiesHealth Technology Designs, develops and sells medical devices | Presidente | 01/01/2024 |
Antiguos cargos conocidos de Nicolas Serandour.
| Empresas | Cargo | Fin |
|---|---|---|
Lazard & Co. Ltd.
Lazard & Co. Ltd. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01/01/2014 |
Formación de Nicolas Serandour.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
Lazard & Co. Ltd.
Lazard & Co. Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Advanced Oncotherapy Plc
Advanced Oncotherapy Plc Medical SpecialtiesHealth Technology Develops and provides advanced cancer treatments | Health Technology |
Université Paris Dauphine-PSL
Université Paris Dauphine-PSL Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ESSEC Business School
ESSEC Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Totally Listed Ltd.
Totally Listed Ltd. Financial ConglomeratesFinance Provides investment services | Finance |
Neurinnov SAS
Neurinnov SAS Medical SpecialtiesHealth Technology Designs, develops and sells medical devices | Health Technology |
- Bolsa de valores
- Insiders
- Nicolas Serandour
















